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The newly developed QA-810V is an optional unit for the
determination of ¢ve-part white blood cell di¡erentials. It can be
used together with the same manufacturer’s haematology analyser
which has been used in relatively small-sized laboratories. The
present study evaluates the basic performance of the QA-810V and
the MEK-8118 haematology analyser using routinely obtained
blood specimens treated with ethylenedioaminetetraacetic acid-2K.
In this evaluation, reproducibility was good and little carryover
was found. Accurate measurements were possible for up to 24h of
storage. Storage at 48C yielded more stable measurements of
complete blood counts and ¢ve-part di¡erentials than storage at
room temperature. A good correlation between ¢ndings with the
MEK-8118 haematology analyser and those with the SE-9000
haematology analyser was found for complete blood counts. The
leukocyte di¡erential obtained with the QA-810V correlated well
with eye counts, with r> 0.9 for percentages of neutrophils,
lymphocytes and eosinophils. Scattergrams obtained with the QA-
810V re£ected the presence of abnormal cells. The performance of
the QA-810V was excellent and it can improve the quality of
testing in clinical laboratories.
Introduction
Haematology analysers with ® ve-part leukocyte diå er-
ential function are now used in sophisticated laboratories.
On the other hand, some small laboratories still use
haematology analysers without the ® ve-part diå erential
function; the reasons for this may vary, but they include
the large investment required for the latest instrumenta-
tion, the small number of specimens assayed for the ® ve-
part diå erential, and the limited space in such labora-
tories. Haematology analysers can screen for abnormal
samples that require further manual diå erential, and the
usefulness of automated leukocyte diå erential for this
purpose is recognized [1]. In addition, screening by the
haematology analysers with the function of the ® ve-part
diå erential is superior to those with the three-part
diå erential or without automated diå erential [2, 3].
The recently developed QA-810V (QA, Nihon Kohden,
Tokyo, Japan) is an optional unit with a ® ve-part
diå erential function designed to be used with Nihon-
Kohden’ s haematology analyser with the function of
three-part diå erential. The investment required can be
minimal for users of these haematology analysers. The
cost and size of the optional unit and the optional unit
together with haematology analyser are for use in rela-
tively small laboratories. The present study performs a
basic evaluation of use of both the QA-810V and MEK-
8118 haematology analyser (MEK, Nihon Kohden).
Materials and methods
Materials
Venous blood treated with ethylenedioaminetetraacetic
acid-2K was processed within 6h after blood collection,
except for stability tests. The samples were randomly
selected from the laboratory routine workload.
Instruments
Complete blood counts (CBC) are determined with the
MEK analyser. Counting of white blood cells, red blood
cells and platelets is based on the impedance method.
Haemoglobin is determined with the haemoglobin-
cyanide method, an internationally recognized standard
method. For determination of leukocyte diå erential,
leukocytes were suspended in the diluent in the instru-
ment, and the cells in a ¯ ow cell were analysed from three
angles using a semiconductor laser light. Cell granularity
was analysed with orthogonal scatter, and the complexity
in the cell was detected with a forward high-angle scatter.
Cell size was determined with a forward low-angle
scatter. By combining the above information, the ® ve-
part diå erential was obtained.
The 22 parameters obtained with the MEK and QA
analysers were: white blood cell count, red blood cell
count, haemoglobin, haematocrit, mean corpuscular vol-
ume, mean corpuscular haemoglobin, mean corpuscular
haemoglobin concentration, red cell distribution width,
platelet count, mean platelet volume, plateletcrit, platelet
distribution width, and percentages and absolute counts
of the ® ve subpopulations of white blood cells.
The MEK with QA was calibrated before this evaluation
and checked with quality control material daily before
the experiments.
Reproducibility
Samples (n ˆ 10) were assayed ® ve times, and the
coeæ cients of variation (CoV) were obtained. The mean
of the CoVs was calculated for each parameter.
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77Carryover test
Triplicate measurements of a high-count (a1± 3) sample
followed by a low-count (b1± 3) sample were performed,
and the carryover eå ect was determined using:
Carryover ˆ ‰b1 ¡ …b2 ‡ b3†=2Š=‰…a2 ‡ a3†=2Š:
Stability during storage
Samples from healthy adults (n= 3) were stored for up to
48h, and the changes in the obtained parameters during
storage were determined. Each sample was stored in two
tubes, one at 48C and one at room temperatures (258C),
and measured at 0, 4, 8, 12, 24 and 48h after blood
collection. The samples stored at 48C were left at room
temperature for 10min before measurements. Changes
were evaluated as the mean of actual values of three
samples at each time assayed and the percent changes in
parameters calculated for each sample with the percent-
age at 0h set as 100%.
Comparability with other methods
The samples were processed on the MEK with QA and
on the laboratory’ s routine haematology analyser (SE-
9000, Sysmex Corp., Kobe, Japan). The CBC obtained
with the two instruments were compared. For leukocyte
diå erentials, manual diå erential counts routinely per-
formed (100 counts) were used for comparison. Medical
technologists with more than 10 years of experience
performed 100 cell diå erential counts on May± Gru « n-
wald± Giemsa-stained peripheral blood ® lms prepared
by the wedge method.
Results
Reproducibility
The mean CoVs for CBC varied from 0.5 to 2.5% (table
1). For leukocyte diå erential percentages, CoVs ranged
from 1.9% for neutrophils to 45.2% for basophils.
Carryover
The mean high and low white blood cell counts were
19.63 and 0.6 (£ 10
3/ml); those for red blood cell count
were 5.15 and 0.97 (£ 10
6/ml); and those for platelet
count were 558.0 and 21.7 (£ 10
3/ml). Carryover for
white blood cell count was 0%, while those for both red
blood cell and platelet counts were 0.68 and 0.36%
respectively.
Stability during storage at 48C and room temperature (table 2)
The CBC parameters were stable for up to 24h of storage
regardless of temperature. After 24 h of storage, mean
corpuscular volume tended to increase at room tempera-
ture but was stable at 48C. Changes in other parameters
were larger, although percent changes were < 4% at 48C
and ¹5% at room temperature.
The percent changes up to 48h were within 10% for
%neutrophils and %lymphocytes. The changes in other
subpopulations appeared to be high, but the actual
changes in percentages in diå erentials were < 1% for
12h of storage at both temperatures. Even for storage of
24h, the actual changes were at most 3.7%.
Comparability with other methods (table 3)
The correlations for ® ve major CBC parameters
(n ˆ 768) between results obtained with the MEK and
SE-9000 analysers are shown in table 2. Correlation
coeæ cients ranged from 0.984 to 0.997. Leukocyte diå er-
ential ® ndings obtained with the QA and the manual
method were compared for 237 samples. The correlation
coeæ cients for %neutrophils, %lymphocytes and %eosi-
nophils were > 0.9 for the two methods. For %basophils,
r was low, although the range of variation for %basophils
was narrow.
Scattergrams
Figure 1 (left) shows a scattergram of the combination of
size and complexity for a normal sample. Lymphocytes,
monocyte and basophils were distributed in the left area,
Table 1. Reproducibility test.
CoV (%) Mean
Parameter (unit) Mean § SD MinºMax Mean § SD MinºMax
WBC (£10
3=ml) 1.29 § 0.31 0.90± 1.83 5.09 § 0.92 3.78± 6.98
RBC (£10
6=ml) 0.70 § 0.34 0.24± 1.32 4.24 § 0.49 3.26± 4.85
Hgb (g/dl) 0.56 § 0.27 0.31± 1.21 13.17 § 1.42 10.36± 14.76
Hct (%) 0.64 § 0.29 0.31± 1.05 38.96 § 3.88 30.74± 43.54
Plt (£10
3=ml) 2.48 § 0.90 1.20± 4.03 186.82 § 65.43 59.20± 266.40
Lym% (%) 2.27 § 1.08 1.13± 4.85 34.78 § 7.79 26.18± 46.34
Mon% (%) 8.05 § 3.96 3.53± 16.32 5.90 § 1.55 4.10± 9.14
Neu% (%) 1.90 § 1.03 0.41± 3.43 54.31 § 8.47 39.90± 64.98
Eos% (%) 8.75 § 5.54 2.76± 21.22 4.74 § 2.16 1.96± 8.74
Bas% (%) 45.18 § 24.34 20.33± 100.00 0.26 § 0.15 0.10± 0.60
SD, standard deviation; CoV, coeæ cient of variation; WBC, white blood cell count; RBC, red blood cell count; Hgb, heamoglobin;
Hct, haematocrit; Plt, platelet count; Lym%, percent lymphocytes; Mon%, percent monoocytes; Neu%, percent neutrophils; Eos%,
percent eosinophils; Bas%, percent basophils.
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the right area. Lymphocytes could be diå erentiated since
they were smaller than monocytes and basophils. Mono-
cytes and basophils could be separated by their diå erence
in granularity (® gure 1, middle), and neutrophils and
eosinophils could be diå erentiated in the same fashion
(® gure 1, right). Ghosts were distributed in the lower
part of the scattergram. For normal samples, individual
clusters of such subpopulations could be clearly observed,
but abnormal scattergrams were obtained for samples
including abnormal cells. Figure 2A is a scattergram of
cord blood with nucleated red blood cells (7/100 white
blood cells) and 15% immature granulocytes (myelocytes
and metamyelocytes) as determined by manual diå eren-
tial. On this scattergram, the border of the area between
lymphocytes and ghosts is diæ cult to ® nd, since atypical
lymphocytes may be distributed there. A large cluster is
found covering the area of monocytes and basophils and
the area of neutrophils and eosinophils. QA exhibited
¯ agging of ` Left Shift’ for this sample. Figure 2B shows a
case of malignant lymphoma, for which 1% blasts, 22%
immature granulocytes and 17% stab cells were found on
manual diå erential. A large cluster is seen in the upper
part of a scattergram. The QA exhibited ¯ agging of ` Left
Shift’ , ` Immature Granulocytes’ and ` Blasts’ for this
sample.
Discussion
The present study was performed to evaluate the basic
function of both the MEK and QA haematology analy-
Table 2. Stability of complete blood count (CBC) and leukocyte differential results.
Time (h)
0 4 8 12 24 48
CBC:
RT WBC 5.67 5.67 5.63 5.63 5.67 5.37
% change 100.00 100.00 99.28 99.42 100.00 94.98
RBC 4.93 4.88 4.88 4.87 4.87 4.78
% change 100.00 99.02 98.97 98.69 98.70 96.97
Hgb 16.03 15.87 15.77 15.67 15.83 15.60
% change 100.00 98.94 98.32 97.69 98.73 97.24
MCV 94.23 94.33 94.37 94.37 96.67 101.07
% change 100.00 100.10 100.14 100.14 102.58 107.25
Plt 184.00 184.33 182.33 182.67 186.33 173.33
% change 100.00 100.08 98.98 99.24 101.34 94.45
4 C WBC 5.77 5.70 5.67 5.70 5.70 5.57
% change 100.00 99.18 98.46 98.94 98.94 96.59
RBC 4.93 4.90 4.93 4.91 4.93 4.87
% change 100.00 99.28 99.84 99.56 99.98 98.67
Hgb 16.10 16.03 15.83 15.83 16.00 15.97
% change 100.00 99.57 98.33 98.35 99.38 99.16
MCV 94.80 94.43 94.50 94.40 94.50 95.23
% change 100.00 99.61 99.68 99.57 99.68 100.45
Plt 186.67 185.67 185.00 182.67 183.33 188.33
% change 100.00 99.51 99.02 97.70 98.17 100.69
Leukocyte di¡erential:
RT Lym% 34.83 35.23 35.17 34.33 33.50 49.80
% change 100.00 101.11 100.28 97.93 95.73 162.56
Mon% 5.30 4.67 5.23 5.57 8.97 19.27
% change 100.00 90.42 102.43 109.26 173.35 362.99
Neu% 57.43 57.50 56.70 57.73 55.33 18.50
% change 100.00 100.12 98.63 100.55 96.95 33.43
Eos% 2.33 2.43 2.73 2.80 5.77 10.33
% change 100.00 125.20 149.60 137.04 336.47 619.00
Bas% 0.10 0.17 0.17 0.20 0.50 2.10
% change 100.00 175.00 100.00 125.00 500.00 1500.00
4 C Lym% 32.63 32.27 32.97 31.90 30.70 30.63
% change 100.00 98.70 101.22 97.38 93.13 93.02
Mon% 4.90 3.53 3.57 4.23 5.47 6.17
% change 100.00 72.68 73.81 87.13 112.92 127.05
Neu% 59.73 61.20 59.77 60.10 58.77 55.33
% change 100.00 102.49 100.11 100.64 98.48 92.60
Eos% 2.57 2.40 2.93 2.63 2.80 3.63
% change 100.00 93.09 126.49 100.96 113.56 152.07
Bas% 0.17 0.60 0.77 1.13 2.27 4.23
% change 100.00 383.33 500.00 783.33 1466.67 2700.00
RT, room temperature; WBC, white blood cell count; RBC, red blood cell count; Hgb, haemoglobin; Hct, haematocrit; Plt, platelet
count; Lym%, percent lymphocytes; Mon%, percent monoocytes; Neu%, percent neutrophils; Eos%, percent eosinophils; Bas%,
percent basophils.
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Stability testing indicated that results were more stable
at 48C than at room temperature for both CBC and
leukocyte diå erential counts and that at 48C the changes
were small even after 24h of storage. In addition, CBC
results obtained with the MEK correlated well with those
obtained with the SE-9000, and the ® ve-part diå erentials
obtained with the QA were comparable with manual
diå erential counts, with good agreement between the two
in percentages of neutrophils, lymphocyte, monocytes
and eosinophils. The coeæ cient of correlation between
manual and automated counts was low for the percent-
age of basophils, but no signi® cant diå erence between the
two methods was found by a paired t-test. Basophils are
diæ cult to quantitate on most haematology analysers
because they are relatively few in number. With the
Table 3. Comparability of results obtained with the MEK-8118 and QA-810V.
x y n · x x § 1 SD · y y § 1 SD r y ˆ ax ‡ b
Complete blood counts:
WBC SE-9000 MEK 768 6.221 § 2.977 6.326 § 2.958 0.997 0.990 x ‡ 0:167
RBC SE-9000 MEK 768 4.042 § 0.673 3.995 § 0.655 0.996 0.968 x ‡ 0:081
Hgb SE-9000 MEK 768 12.296 § 1.980 12.383 § 1.974 0.997 0.994 x ‡ 0:159
Hct SE-9000 MEK 768 36.953 § 5.674 36.813 § 5.699 0.991 0.996 x ‡ 0:022
Plt SE-9000 MEK 768 227.217 § 105.129 227.305 § 102.023 0.984 0.955 x ‡ 10:278
Five-part di¡erential of white blood cells:
Neu % mannual MEK 237 65.932 § 18.218 64.068 § 17.614 0.931 0.900 x ‡ 4:730
diå erential
Lym% mannual MEK 237 22.287 § 15.338 24.922 § 15.827 0.940 0.970 x ‡ 3:298
diå erential
Mon% mannual MEK 237 6.253 § 4.259 6.581 § 4.159 0.740 0.723 x ‡ 2:063
diå erential
Eos% mannual MEK 237 3.730 § 6.052 3.565 § 4.580 0.932 0.705 x ‡ 0:934
diå erential
Bas% mannual MEK 237 0.658 § 0.960 0.865 § 0.789 0.132 0.109 x ‡ 0:793
diå erential
WBC, white blood cell count; RBC, red blood cell count; Hgb, haemoglobin; Hct, haematocrit; Plt, platelet count; Neu%, percent
neutrophils; Lym%, percent lymphocytes; Mon%, percent monocytes; Eos%, percent eosinophils; Bas%, percent basophils.
Figure 1. Normal scattergram. Neu, neutrophils; Lym, lymphocytes; Mon, monocytes; Eos, eosinophils; Bas, basophils.
Figure 2. Abnormal scattergrams. A, cord blood; B, malignant lymphoma.
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alities could be detected by observation of the scatter-
gram of complexity and size. This scattergram clearly
reveals the position of each subpopulation, and thus
should be useful clinically. Overall, the results of the
evaluation were favourable and similar to those for other
instruments with ® ve-part diå erentials.
Recent economic constraints have forced clinical labora-
tories to merge in order to optimize their cost structure.
Reimbursement for clinical assays will decrease and
clinical laboratories, regardless of their sizes, must corre-
spondingly make signi® cant improvement in eæ ciency
and generate signi® cant cost savings. Thus, clinical lab-
oratories must try to minimize investment, and manu-
facturers must consider the development of instruments
that meet the above users’ needs. Manufacturers must
develop smaller and more inexpensive instruments [4± 6].
At the same time, implementation of quality systems has
been emphasized in laboratories. This trend is strong
especially in the USA since the National Committee of
Clinical Laboratory Standards, the Food and Drug
Administration and the College of American Pathologists
review the guidelines for haematology testings and plan
to revise them to improve quality systems [7, 8]. The
eå ects of these revisions will soon spread to other coun-
tries. Haematology systems are expected to meet revised
criteria for quality systems, and thus neither instruments
that require signi® cant investment nor small but unreli-
able instruments are any longer required. The QA was
for this reason developed for use with the MEK haema-
tology analyser. For users possessing Nihon Kohden’ s
haematology analyser, the investment required for the
QA can be minimal (at most one-quarter that required
for other haematology analysers with ® ve-part diå eren-
tials) since users need only purchase the optional unit to
improve their quality of screening for morphologically
abnormal samples. Even the MEK with QA is still less
expensive than other haematology analysers with ® ve-
part diå erentials now on the market in Japan.
In conclusion, the QA will improve clinical laboratory
productivity and eæ ciency, and the increase in the detail
of automated examination it enables will improve both
the quality and quantity of laboratory testing. A haema-
tology analyser with a maximum capability to generate a
reliable automated haematology results, a good under-
standing of analyser limitations and documented review
criteria developed by the laboratory to direct the actions
taken based on automated results are essential for the
success for good laboratory practice.
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